End-stage heart failure is still associated with a decrease in quality and
prognosis of life. Cardiac transplantation remains the final extraordinary
therapeutic option for the treatment of truly irreversible end-stage heart
failure in all age groups. The selection process of candidates and the acce
ptance of patients with relative contra-indications is characterized by the
experience and skills of an interdisciplinary transplant team, which shoul
d have access to different mechanical circulatory support systems for short
-term or long-term use: bridging to transplant as well as for recovery. (C)
2000 Lippincott Williams & Wilkins, Inc.